Clifford Swan Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Clifford Swan Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,982	Closed	-$336K	–	274
2015 Q4	$336K	Buy	2,982 +168	+6%	+$18.2K	0.02%	222
2015 Q3	$285K	Buy	2,814 +993	+55%	+$119K	0.02%	223
2015 Q2	$224K	Sell	1,821 -36	-2%	-$4.31K	0.02%	239
2015 Q1	$213K	Buy	+1,857	New	+$205K	0.01%	244

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Clifford Swan Investment Counsel's IBB Position: Q1 2016 in Review

Clifford Swan Investment Counsel sold out of iShares Biotechnology ETF (IBB) in Q1 2016, closing a stake of 2,982 shares — an estimated $336K sold.

Clifford Swan Investment Counsel first reported a position in IBB in Q1 2015 and held it in 4 quarters. The position peaked at $336K in Q4 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q1 2016.

Clifford Swan Investment Counsel reported no remaining iShares Biotechnology ETF position as of Q1 2016 after selling out during the quarter.
Clifford Swan Investment Counsel sold 2,982 iShares Biotechnology ETF shares in Q1 2016, an estimated $336K.
Clifford Swan Investment Counsel first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 4 quarters.
Clifford Swan Investment Counsel's iShares Biotechnology ETF position peaked at $336K in Q4 2015.
415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2016.

Based on Clifford Swan Investment Counsel's 13F filing for Q1 2016, filed 16 May 2016.